Bristol-Myers Squibb (BMY)
Frequently Asked Questions About Bristol-Myers Squibb (BMY)
How does Bristol-Myers Squibb approach corporate social responsibility?
Bristol-Myers Squibb is committed to corporate social responsibility, focusing on improving health globally through access to medicines, community engagement, and environmental sustainability. The company participates in initiatives that aim to enhance healthcare access for underserved populations and minimize its environmental impact.
How does Bristol-Myers Squibb contribute to the global health landscape?
Bristol-Myers Squibb contributes to the global health landscape by advancing research in diseases that significantly impact global health, providing access to medicines through philanthropic endeavors, and partnered health initiatives. These efforts reflect the company's commitment to improving health outcomes worldwide.
How does Bristol-Myers Squibb engage in research and development?
Bristol-Myers Squibb invests heavily in research and development (R&D), dedicating a significant portion of its revenue to discovering and developing new drugs. The company collaborates with academic institutions, biotech firms, and clinical researchers to drive innovation and bring transformative therapies to market.
How does Bristol-Myers Squibb ensure drug safety?
Bristol-Myers Squibb adheres to strict regulatory standards to ensure the safety and efficacy of its drugs. This includes comprehensive clinical evaluations, post-marketing surveillance, and adverse event reporting, ensuring all products in the market are monitored and refined based on the latest safety data.
How is Bristol-Myers Squibb responding to COVID-19?
Bristol-Myers Squibb has actively responded to the COVID-19 pandemic by adjusting its clinical trials, ensuring patient safety, and supporting healthcare providers. The company has also contributed to research on COVID-19 treatments and engaged in community support initiatives to aid those affected by the pandemic.
Is Bristol-Myers Squibb involved in any partnerships or collaborations?
Yes, Bristol-Myers Squibb actively engages in partnerships and collaborations with various biopharmaceutical companies, research institutions, and academic organizations. These collaborations focus on sharing expertise, resources, and technology to accelerate drug development and improve patient outcomes.
What are Bristol-Myers Squibb’s commitments to sustainability?
Bristol-Myers Squibb is committed to sustainability through initiatives aimed at reducing its carbon footprint, minimizing waste, and promoting sustainable sourcing. The company actively engages in environmental stewardship to promote ecological health while ensuring the responsible manufacturing of its pharmaceuticals.
What are some key products of Bristol-Myers Squibb?
Bristol-Myers Squibb's portfolio includes several key products such as Opdivo (nivolumab), a cancer immunotherapy, and Eliquis (apixaban), an anticoagulant. Other notable medications include Yervoy (ipilimumab), Orencia (abatacept), and Sprycel (dasatinib), which target various medical conditions.
What does Bristol-Myers Squibb do?
Bristol-Myers Squibb is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines for serious diseases. With a strong commitment to research and development, the company primarily targets areas such as oncology, immunology, cardiovascular disease, and fibrosis.
What is Bristol-Myers Squibb's financial performance like?
Bristol-Myers Squibb has demonstrated strong financial performance over the years, driven by successful drug launches and acquisitions. The company's revenues have steadily increased, reflecting robust sales of key products and effective expense management, which provides a solid foundation for future growth.
What is Bristol-Myers Squibb's mission?
Bristol-Myers Squibb's mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. The company aims to improve patients' lives through scientific discovery, clinical trials, and emphasizing patient-centered healthcare.
What is Bristol-Myers Squibb's pipeline of drugs like?
Bristol-Myers Squibb has a robust pipeline of drugs in various stages of development, targeting multiple diseases, including cancer, autoimmune disorders, and cardiovascular diseases. The company emphasizes innovation in traditional small molecules and advanced therapies like cell and gene editing.
What is the culture like at Bristol-Myers Squibb?
Bristol-Myers Squibb fosters a culture of innovation, collaboration, and integrity. The company encourages diversity and inclusion among its workforce, empowering employees to contribute to its mission of advancing health and well-being across communities.
What is the significance of Opdivo in Bristol-Myers Squibb's portfolio?
Opdivo (nivolumab) is one of Bristol-Myers Squibb's flagship immunotherapy drugs, specifically designed to help the immune system fight cancer. It has shown remarkable efficacy in treating various cancers, including melanoma, lung cancer, and kidney cancer, making it a cornerstone of the company's oncology division.
What role does biotechnology play in Bristol-Myers Squibb's operations?
Biotechnology is central to Bristol-Myers Squibb's operations as the company leverages biomanufacturing, antibody engineering, and cellular technologies to develop innovative therapies. This includes the use of monoclonal antibodies and other biologics that have transformed treatment protocols in various medical fields.
What therapeutic areas does Bristol-Myers Squibb focus on?
Bristol-Myers Squibb primarily focuses on therapeutic areas including oncology, immunology, cardiovascular diseases, and fibrotic diseases. The company aims to address unmet medical needs through innovative therapies that target these critical health issues.
When was Bristol-Myers Squibb founded?
Bristol-Myers Squibb was formed in 1989 through the merger of two companies: Bristol-Myers Company, founded in 1887, and Squibb Corporation, established in 1858. This merger was aimed at combining resources and expertise to develop more effective pharmaceutical treatments.
Where is Bristol-Myers Squibb headquartered?
Bristol-Myers Squibb is headquartered in New York City, New York. The company's corporate office serves as the central hub for strategic decision-making and corporate governance, guiding its global operations.
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 59.60
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 6:30 pm EDT on April 2nd, 2025
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 132.44B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 2.22B shares outstanding.